Literature DB >> 31999474

Method Validation for Extraction of DNA from Human Stool Samples for Downstream Microbiome Analysis.

Lorie Neuberger-Castillo1, Gaël Hamot1, Monica Marchese1, Ignacio Sanchez1, Wim Ammerlaan1, Fay Betsou1.   

Abstract

Background: A formal method validation for biospecimen processing in the context of accreditation in laboratories and biobanks is lacking. A previously optimized stool processing protocol was validated for fitness-for-purpose for downstream microbiome analysis. Materials and
Methods: DNA extraction from human stool was validated with various collection tubes, stabilizing solutions and storage conditions in terms of fitness-for-purpose for downstream microbiome analysis, robustness, and sample stability. Acceptance criteria were based on accurate identification of a reference material, homogeneity of extracted samples, and sample stability in a 2-year period.
Results: The automated DNA extraction using the chemagic™ Magnetic Separation Module I (MSM I) extracted 8 out of 8 bacteria in the ZymoBIOMICS® Microbial Community Standard. Seven tested stabilizing solutions (OMNIgene®•GUT, RNAlater®, AquaStool™, RNAssist, PerkinElmer SEB lysis buffer, and DNA Genotek's CP-150) were all compatible with the chemagic MSM I and showed no significant difference in microbiome alpha diversity and no significant difference in the overall microbiome composition compared to the baseline snap-frozen stool sample. None of the stabilizing solutions showed intensive polymerase chain reaction (PCR) inhibition in the SPUD assay. However, when we take into account more stringent criteria which include a higher double-stranded DNA yield, higher DNA purity, and absence of PCR inhibition, we recommend the use of OMNIgene•GUT, RNAlater, or AquaStool as alternatives to rapid freezing of samples. The highest sample homogeneity was achieved with RNAlater- and OMNIgene•GUT -stabilized samples. Sample stability after a 2-year storage in -80°C was seen with OMNIgene•GUT -stabilized samples. Conclusions: We validated a combination of a stool processing method with various collection methods, suitable for downstream microbiome applications. Sample collection, storage conditions and DNA extraction methods can influence the microbiome profile results. Laboratories and biobanks should ensure that these conditions are systematically recorded in the scope of accreditation.

Entities:  

Keywords:  16S; biobank; fit-for-purpose; microbiome; stool; validation

Mesh:

Substances:

Year:  2020        PMID: 31999474     DOI: 10.1089/bio.2019.0112

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  5 in total

1.  Fitness for purpose of stabilized stool samples for bile acid metabolite analyses.

Authors:  Lorie Neuberger-Castillo; Wim Ammerlaan; Fay Betsou
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

2.  Gut Microbiota and Serum Metabolome in Elite Cross-Country Skiers: A Controlled Study.

Authors:  Jukka E Hintikka; Eveliina Munukka; Maarit Valtonen; Raakel Luoto; Johanna K Ihalainen; Teemu Kallonen; Matti Waris; Olli J Heinonen; Olli Ruuskanen; Satu Pekkala
Journal:  Metabolites       Date:  2022-04-07

3.  Standards for Collection, Preservation, and Transportation of Fecal Samples in TCM Clinical Trials.

Authors:  Wenquan Su; Yawei Du; Fengmei Lian; Hui Wu; Xinrong Zhang; Wenli Yang; Yunfeng Duan; Yuanming Pan; Weijng Liu; Aiming Wu; Bowen Zhao; Chongming Wu; Shengxian Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-04-20       Impact factor: 6.073

4.  Example for process validation in biobanking: Fit for purpose testing of a cryopreservation method without isopentane.

Authors:  Monika Wieser; Stefanie Burger; Reinhard Ertl; Stefan Kummer; Melanie Stargardt; Ingrid Walter
Journal:  Front Mol Biosci       Date:  2022-09-30

5.  Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.

Authors:  Federico Baldini; Johannes Hertel; Estelle Sandt; Cyrille C Thinnes; Lorieza Neuberger-Castillo; Lukas Pavelka; Fay Betsou; Rejko Krüger; Ines Thiele
Journal:  BMC Biol       Date:  2020-06-09       Impact factor: 7.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.